Episode 156: ASCO GU 2022 1st line olaparib and durvalumab in bladder cancer
The Uromigos - Een podcast door The Uromigos

Jonathan Rosenberg describes the results of this positive randomised trial.
The Uromigos - Een podcast door The Uromigos
Jonathan Rosenberg describes the results of this positive randomised trial.